Sustained response to anlotinib in advanced pancreatic neuroendocrine carcinoma: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained response to anlotinib in advanced pancreatic neuroendocrine carcinoma: A case report

Published:2024-02-02 Issue:4 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhang Yan¹,Wang Yanchun¹,Wu Jingjing¹,Zhong Zhihong²,Li Jie¹,Chen Xi¹

Affiliation:

1. Department of Oncology, The 900th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Fuzong Clinical College of Fujian Medical University, Fuzhou, Fujian 350025, P.R. China

2. Department of Gastroenterology, People's Hospital of Fuan City, Ningde, Fujian 355000, P.R. China

Publisher

Spandidos Publications

Reference11 articles.

1. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin;Basu;Endocr Relat Cancer,2010

2. The 2019 WHO classification of tumours of the digestive system;Nagtegaal;Histopathology,2020

3. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Onco,2017

4. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas;Iwasa;Jpn J Clin Oncol,2010

5. Tyrosine kinase inhibitors and immunotherapy updates in neuroendocrine neoplasms;Mosalem;Best Pract Res Clin Endocrinol Metab,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP